Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 10/2009

01-10-2009 | Article

The unusual antibacterial activity of medical-grade Leptospermum honey: antibacterial spectrum, resistance and transcriptome analysis

Authors: S. E. Blair, N. N. Cokcetin, E. J. Harry, D. A. Carter

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 10/2009

Login to get access

Abstract

There is an urgent need for new, effective agents in topical wound care, and selected honeys show potential in this regard. Using a medical-grade honey, eight species of problematic wound pathogens, including those with high levels of innate or acquired antibiotic resistance, were killed by 4.0–14.8% honey, which is a concentration that can be maintained in the wound environment. Resistance to honey could not be induced under conditions that rapidly induced resistance to antibiotics. Escherichia coli macroarrays were used to determine the response of bacterial cells to a sub-lethal dose of honey. The pattern of gene expression differed to that reported for other antimicrobial agents, indicating that honey acts in a unique and multifactorial way; 78 (2%) genes were upregulated and 46 (1%) genes were downregulated more than two-fold upon exposure to the medical-grade honey. Most of the upregulated genes clustered into distinct functional regulatory groups, with many involved in stress responses, and the majority of downregulated genes encoded for products involved in protein synthesis. Taken together, these data indicate that honey is an effective topical antimicrobial agent that could help reduce some of the current pressures that are promoting antibiotic resistance.
Appendix
Available only for authorised users
Literature
1.
3.
go back to reference Paterson DL (2006) The epidemiological profile of infections with multidrug-resistant Pseudomonas aeruginosa and Acinetobacter species. Clin Infect Dis 43:S43–S48. doi:10.1086/504476 PubMedCrossRef Paterson DL (2006) The epidemiological profile of infections with multidrug-resistant Pseudomonas aeruginosa and Acinetobacter species. Clin Infect Dis 43:S43–S48. doi:10.​1086/​504476 PubMedCrossRef
4.
go back to reference Spellberg B, Guidos R, Gilbert D, Bradley J, Boucher HW, Scheld WM, Bartlett JG, Edwards J Jr; Infectious Diseases Society of America (2008) The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America. Clin Infect Dis 46:155–164. doi:10.1086/524891 PubMedCrossRef Spellberg B, Guidos R, Gilbert D, Bradley J, Boucher HW, Scheld WM, Bartlett JG, Edwards J Jr; Infectious Diseases Society of America (2008) The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America. Clin Infect Dis 46:155–164. doi:10.​1086/​524891 PubMedCrossRef
7.
go back to reference Quentin C, Arpin C, Dubois V, André C, Lagrange I, Fischer I, Brochet JP, Grobost F, Jullin J, Dutilh B, Larribet G, Noury P (2004) Antibiotic resistance rates and phenotypes among isolates of Enterobacteriaceae in French extra-hospital practice. Eur J Clin Microbiol Infect Dis 23:185–193. doi:10.1007/s10096-003-1081-5 PubMedCrossRef Quentin C, Arpin C, Dubois V, André C, Lagrange I, Fischer I, Brochet JP, Grobost F, Jullin J, Dutilh B, Larribet G, Noury P (2004) Antibiotic resistance rates and phenotypes among isolates of Enterobacteriaceae in French extra-hospital practice. Eur J Clin Microbiol Infect Dis 23:185–193. doi:10.​1007/​s10096-003-1081-5 PubMedCrossRef
9.
go back to reference Hujer KM, Hujer AM, Hulten EA, Bajaksouzian S, Adams JM, Donskey CJ, Ecker DJ, Massire C, Eshoo MW, Sampath R, Thomson JM, Rather PN, Craft DW, Fishbain JT, Ewell AJ, Jacobs MR, Paterson DL, Bonomo RA (2006) Analysis of antibiotic resistance genes in multidrug-resistant Acinetobacter sp. isolates from military and civilian patients treated at the Walter Reed Army Medical Center. Antimicrob Agents Chemother 50:4114–4123. doi:10.1128/AAC.00778-06 PubMedCrossRef Hujer KM, Hujer AM, Hulten EA, Bajaksouzian S, Adams JM, Donskey CJ, Ecker DJ, Massire C, Eshoo MW, Sampath R, Thomson JM, Rather PN, Craft DW, Fishbain JT, Ewell AJ, Jacobs MR, Paterson DL, Bonomo RA (2006) Analysis of antibiotic resistance genes in multidrug-resistant Acinetobacter sp. isolates from military and civilian patients treated at the Walter Reed Army Medical Center. Antimicrob Agents Chemother 50:4114–4123. doi:10.​1128/​AAC.​00778-06 PubMedCrossRef
10.
go back to reference O’Callaghan A, Redmond HP (2006) Treatment of sepsis: current status of clinical immunotherapy. Surgeon 4:355–361PubMedCrossRef O’Callaghan A, Redmond HP (2006) Treatment of sepsis: current status of clinical immunotherapy. Surgeon 4:355–361PubMedCrossRef
15.
go back to reference Lotfi A (2008) Use of honey as a medicinal product in wound dressing (human and animal studies): a review. Res J Bio Sci 3:136–140 Lotfi A (2008) Use of honey as a medicinal product in wound dressing (human and animal studies): a review. Res J Bio Sci 3:136–140
16.
go back to reference Jull A, Walker N, Parag V, Molan P, Rodgers A; Honey as Adjuvant Leg Ulcer Therapy trial collaborators (2008) Randomized clinical trial of honey-impregnated dressings for venous leg ulcers. Br J Surg 95:175–182. doi:10.1002/bjs.6059 PubMedCrossRef Jull A, Walker N, Parag V, Molan P, Rodgers A; Honey as Adjuvant Leg Ulcer Therapy trial collaborators (2008) Randomized clinical trial of honey-impregnated dressings for venous leg ulcers. Br J Surg 95:175–182. doi:10.​1002/​bjs.​6059 PubMedCrossRef
19.
go back to reference Blaser G, Santos K, Bode U, Vetter H, Simon A (2007) Effect of medical honey on wounds colonised or infected with MRSA. J Wound Care 16:325–328PubMed Blaser G, Santos K, Bode U, Vetter H, Simon A (2007) Effect of medical honey on wounds colonised or infected with MRSA. J Wound Care 16:325–328PubMed
21.
go back to reference Molan PC (1992) The antibacterial activity of honey. 1. The nature of the antibacterial activity. Bee World 73:5–28 Molan PC (1992) The antibacterial activity of honey. 1. The nature of the antibacterial activity. Bee World 73:5–28
22.
23.
go back to reference Allen KL, Molan PC, Reid GM (1991) A survey of the antibacterial activity of some New Zealand honeys. J Pharm Pharmacol 43:817–822PubMed Allen KL, Molan PC, Reid GM (1991) A survey of the antibacterial activity of some New Zealand honeys. J Pharm Pharmacol 43:817–822PubMed
24.
25.
go back to reference Mavric E, Wittmann S, Barth G, Henle T (2008) Identification and quantification of methylglyoxal as the dominant antibacterial constituent of Manuka (Leptospermum scoparium) honeys from New Zealand. Mol Nutr Food Res 52:483–489. doi:10.1002/mnfr.200700282 PubMedCrossRef Mavric E, Wittmann S, Barth G, Henle T (2008) Identification and quantification of methylglyoxal as the dominant antibacterial constituent of Manuka (Leptospermum scoparium) honeys from New Zealand. Mol Nutr Food Res 52:483–489. doi:10.​1002/​mnfr.​200700282 PubMedCrossRef
29.
go back to reference Hutter B, Schaab C, Albrecht S, Borgmann M, Brunner NA, Freiberg C, Ziegelbauer K, Rock CO, Ivanov I, Loferer H (2004) Prediction of mechanisms of action of antibacterial compounds by gene expression profiling. Antimicrob Agents Chemother 48:2838–2844. doi:10.1128/AAC.48.8.2838-2844.2004 PubMedCrossRef Hutter B, Schaab C, Albrecht S, Borgmann M, Brunner NA, Freiberg C, Ziegelbauer K, Rock CO, Ivanov I, Loferer H (2004) Prediction of mechanisms of action of antibacterial compounds by gene expression profiling. Antimicrob Agents Chemother 48:2838–2844. doi:10.​1128/​AAC.​48.​8.​2838-2844.​2004 PubMedCrossRef
33.
go back to reference Alvarez J, Vicente M (2007) Using genomics to identify new targets and counteract resistance to antibiotics. Expert Opin Ther Pat 17:667–674CrossRef Alvarez J, Vicente M (2007) Using genomics to identify new targets and counteract resistance to antibiotics. Expert Opin Ther Pat 17:667–674CrossRef
35.
go back to reference NCCLS (2000) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. NCCLS Document Approved Standard—Fifth edition NCCLS (2000) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. NCCLS Document Approved Standard—Fifth edition
40.
go back to reference Eguchi Y, Oshima T, Mori H, Aono R, Yamamoto K, Ishihama A, Utsumi R (2003) Transcriptional regulation of drug efflux genes by EvgAS, a two-component system in Escherichia coli. Microbiology 149:2819–2828. doi:10.1099/mic.0.26460-0 PubMedCrossRef Eguchi Y, Oshima T, Mori H, Aono R, Yamamoto K, Ishihama A, Utsumi R (2003) Transcriptional regulation of drug efflux genes by EvgAS, a two-component system in Escherichia coli. Microbiology 149:2819–2828. doi:10.​1099/​mic.​0.​26460-0 PubMedCrossRef
42.
go back to reference Simon A, Traynor K, Santos K, Blaser G, Bode U, Molan P (2009) Medical honey for wound care—still the ‘latest resort’? eCAM 6:165–173. doi:10.1093/ecam/nem175 Simon A, Traynor K, Santos K, Blaser G, Bode U, Molan P (2009) Medical honey for wound care—still the ‘latest resort’? eCAM 6:165–173. doi:10.​1093/​ecam/​nem175
43.
go back to reference Blair SE, Carter DA (2005) The potential for honey in the management of wounds and infection. Aust Infect Contr 10:24–31 Blair SE, Carter DA (2005) The potential for honey in the management of wounds and infection. Aust Infect Contr 10:24–31
48.
go back to reference Booth IR, Ferguson GP, Miller S, Li C, Gunasekera B, Kinghorn S (2003) Bacterial production of methylglyoxal: a survival strategy or death by misadventure? Biochem Soc Trans 31:1406–1408. doi:10.1042/BST0311406 PubMedCrossRef Booth IR, Ferguson GP, Miller S, Li C, Gunasekera B, Kinghorn S (2003) Bacterial production of methylglyoxal: a survival strategy or death by misadventure? Biochem Soc Trans 31:1406–1408. doi:10.​1042/​BST0311406 PubMedCrossRef
49.
go back to reference Crane E (1976) Honey, a comprehensive survey. London: Heinemann (for the Bee Research Association), p 608 Crane E (1976) Honey, a comprehensive survey. London: Heinemann (for the Bee Research Association), p 608
50.
go back to reference Moreillon P (2000) Means of bacterial resistance. Rev Med Suisse Romande 120:641–650PubMed Moreillon P (2000) Means of bacterial resistance. Rev Med Suisse Romande 120:641–650PubMed
54.
go back to reference Goh EB, Yim G, Tsui W, McClure J, Surette MG, Davies J (2002) Transcriptional modulation of bacterial gene expression by subinhibitory concentrations of antibiotics. Proc Natl Acad Sci USA 99:17025–17030. doi:10.1073/pnas.252607699 PubMedCrossRef Goh EB, Yim G, Tsui W, McClure J, Surette MG, Davies J (2002) Transcriptional modulation of bacterial gene expression by subinhibitory concentrations of antibiotics. Proc Natl Acad Sci USA 99:17025–17030. doi:10.​1073/​pnas.​252607699 PubMedCrossRef
60.
go back to reference Ferguson GP, Creighton RI, Nikolaev Y, Booth IR (1998) Importance of RpoS and Dps in survival of exposure of both exponential- and stationary-phase Escherichia coli cells to the electrophile N-ethylmaleimide. J Bacteriol 180:1030–1036PubMed Ferguson GP, Creighton RI, Nikolaev Y, Booth IR (1998) Importance of RpoS and Dps in survival of exposure of both exponential- and stationary-phase Escherichia coli cells to the electrophile N-ethylmaleimide. J Bacteriol 180:1030–1036PubMed
64.
go back to reference Brady NF, Molan PC, Harfoot CG (1996) The sensitivity of dermatophytes to the antimicrobial activity of manuka honey and other honey. Pharm Sci 2:471–473 Brady NF, Molan PC, Harfoot CG (1996) The sensitivity of dermatophytes to the antimicrobial activity of manuka honey and other honey. Pharm Sci 2:471–473
67.
go back to reference Clugston SL, Honek JF (2000) Identification of sequences encoding the detoxification metalloisomerase glyoxalase I in microbial genomes from several pathogenic organisms. J Mol Evol 50:491–495PubMed Clugston SL, Honek JF (2000) Identification of sequences encoding the detoxification metalloisomerase glyoxalase I in microbial genomes from several pathogenic organisms. J Mol Evol 50:491–495PubMed
69.
go back to reference Misra K, Banerjee AB, Ray S, Ray M (1995) Glyoxalase III from Escherichia coli: a single novel enzyme for the conversion of methylglyoxal into D-lactate without reduced glutathione. Biochem J 305:999–1003PubMed Misra K, Banerjee AB, Ray S, Ray M (1995) Glyoxalase III from Escherichia coli: a single novel enzyme for the conversion of methylglyoxal into D-lactate without reduced glutathione. Biochem J 305:999–1003PubMed
Metadata
Title
The unusual antibacterial activity of medical-grade Leptospermum honey: antibacterial spectrum, resistance and transcriptome analysis
Authors
S. E. Blair
N. N. Cokcetin
E. J. Harry
D. A. Carter
Publication date
01-10-2009
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 10/2009
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-009-0763-z

Other articles of this Issue 10/2009

European Journal of Clinical Microbiology & Infectious Diseases 10/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.